Wikidata entity: Q417542
C₂₂H₂₇FN₄O₂ (P274)
Quantities
| P2067 | mass | 398.212 |
| P3780 | active ingredient in | ... | Q29006518 (Sutent) | Sutent |
| P233 | canonical SMILES | String | CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C | ??? |
| P373 | Commons category | String | Sunitinib | ??? |
| P703 | found in taxon | ... | Q15020954 (Penicillium solitum) | Penicillium solitum |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P527 | has part(s) | ... | Q650 (fluorine) | fluorine |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Sunitinib-3D-balls.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C | ??? |
| P8026 | LiverTox likelihood score | ... | Q83284157 (LiverTox toxicity likelihood category B) | LiverTox toxicity likelihood category B |
| P2175 | medical condition treated | ... | Q56014392 (rare urinary tract tumor) | rare urinary tract tumor |
| P2175 | medical condition treated | ... | Q18553565 (gastrointestinal carcinoma) | gastrointestinal carcinoma |
| P2175 | medical condition treated | ... | Q18554913 (neuroendocrine carcinoma) | neuroendocrine carcinoma |
| P2175 | medical condition treated | ... | Q18555361 (thymus cancer) | thymus cancer |
| P2175 | medical condition treated | ... | Q18556340 (renal clear cell carcinoma) | renal clear cell carcinoma |
| P2175 | medical condition treated | ... | Q212961 (pancreatic cancer) | pancreatic cancer |
| P2175 | medical condition treated | ... | Q1495661 (gastrointestinal stromal tumor) | gastrointestinal stromal tumor |
| P2175 | medical condition treated | ... | Q1734755 (carcinoid tumor) | carcinoid tumor |
| P2175 | medical condition treated | ... | Q1989240 (renal pelvis carcinoma) | renal pelvis carcinoma |
| P2175 | medical condition treated | ... | Q1164529 (renal cell carcinoma) | renal cell carcinoma |
| P2175 | medical condition treated | ... | Q3242950 (kidney cancer) | kidney cancer |
| P2175 | medical condition treated | ... | Q3542012 (connective tissue neoplasm) | connective tissue neoplasm |
| P129 | physically interacts with | ... | Q21108624 (Platelet derived growth factor receptor beta) | Platelet derived growth factor receptor beta |
| P129 | physically interacts with | ... | Q21118353 (fms related receptor tyrosine kinase 4) | fms related receptor tyrosine kinase 4 |
| P129 | physically interacts with | ... | Q21172390 (kinase insert domain receptor) | kinase insert domain receptor |
| P129 | physically interacts with | ... | Q5446453 (fibroblast growth factor receptor 1) | fibroblast growth factor receptor 1 |
| P129 | physically interacts with | ... | Q415976 (ret proto-oncogene) | ret proto-oncogene |
| P129 | physically interacts with | ... | Q909409 (KIT proto-oncogene, receptor tyrosine kinase) | KIT proto-oncogene, receptor tyrosine kinase |
| P129 | physically interacts with | ... | Q5009781 (fms related receptor tyrosine kinase 3) | fms related receptor tyrosine kinase 3 |
| P3489 | pregnancy category | ... | Q28123618 (US pregnancy category D) | US pregnancy category D |
| P3489 | pregnancy category | ... | Q3679274 (Australian pregnancy category D) | Australian pregnancy category D |
| P769 | significant drug interaction | ... | Q213511 (erythromycin) | erythromycin |
| P769 | significant drug interaction | ... | Q407883 (ketoconazole) | ketoconazole |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q5908266 (idelalisib) | idelalisib |
| P769 | significant drug interaction | ... | Q411229 (itraconazole) | itraconazole |
| P769 | significant drug interaction | ... | Q412236 (voriconazole) | voriconazole |
| P769 | significant drug interaction | ... | Q906453 (posaconazole) | posaconazole |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P9989 | stylized name | String | SUNItinib | ??? |
| P279 | subclass of | ... | Q193430 (heterocyclic compound) | heterocyclic compound |
| P2868 | subject has role | ... | Q7251487 (protein kinase inhibitors) | protein kinase inhibitors |
| P2868 | subject has role | ... | Q2853144 (antineoplastic) | antineoplastic |
| P2868 | subject has role | ... | Q574834 (angiogenesis inhibitor) | angiogenesis inhibitor |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | sunitinib | ??? |
Why not click here or view trends?
log id: 2460789